Seaport Therapeutics

Neuropsychiatric therapeutics biotech Seaport Therapeutics files for a $100 million IPO May 1, 2026 News Neuropsychiatric therapeutics Seaport Therapeutics prices upsized IPO at $18, the high end of the range Seaport Therapeutics, a Phase 2 biotech developing therapies for neuropsychiatric... Read more